Bookmarks
Beta-blocker Stratification using MRI to assess portal pressure (B-SMaRT)
Population Size
46
People
Years
2016
Associated BioSamples
Availability to be confirmed
Geographic coverage
United Kingdom
England
Lead time
Not applicable
Summary
Documentation
Beta-blocker Stratification using quantitative MRI techniques to assess portal pressure and Response to Treatment in patients with portal hypertension (B-SMaRT study).
To provide proof of concept that quantitative haemodynamic MRI markers can stratify the efficacy of carvedilol to lower clinically significant portal hypertension in patients with cirrhosis.
Descriptive sequential pilot study of patients with cirrhosis, portal pressure measurement, research MRI (at 3T) and endoscopy with outcomes with repeat measures in those who are given Carvedilol
Keywords
Observations
Observed Node | Disambiguating Description | Measured Value | Measured Property | Observation Date |
---|---|---|---|---|
Persons | 46 | Count | 01 Aug 2016 |
Provenance
Details
08/10/2024
Coverage
01/08/2016